FARMORUBICINE Side Effects

6985393-3 | Hyponatraemia
on Sep 03, 2010 Female patient from FRANCE , 57 years of age, was diagnosed with breast cancer in situ and was treated with Farmorubicine (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia. Farmorubicine dosage: 1 Df, Single. During the same period patient was treated with ENDOXAN (1 Df, Single (500 Mg/m2)) (View Endoxan Review and Endoxan Label ), FOLINIC ACID (Unk) (View Folinic Acid Review and Folinic Acid Label ).

6976054-5 | Torsade De Pointes
Patient was taking Farmorubicine (View Usage). Patient had the following side effects: torsade de pointes on Aug 31, 2010 from FRANCE Additional patient health information: Female patient , 59 years of age, was diagnosed with hepatic neoplasm malignant, portal hypertension, varices oesophageal and. Farmorubicine dosage: 100 Mg, Single. During the same period patient was treated with PROPRANOLOL (160 Mg, 1x/day) (View Propranolol Review and Propranolol Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), ACTOS (View Actos Review and Actos Label ). Patient was hospitalized.

6976047-8 | Hepatitis Toxic
Adverse event was reported on Aug 31, 2010 by a Female patient taking Farmorubicine (View Usage) (Dosage: 100 Mg, Single) was diagnosed with hepatic neoplasm malignant, portal hypertension, varices oesophageal and. Location: FRANCE , 59 years of age, After Farmorubicine was administered, patient had the following side effects: hepatitis toxic. During the same period patient was treated with SUCRALFATE (View Sucralfate Review and Sucralfate Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), ACTOS (View Actos Review and Actos Label ), DIFFU K (View Diffu K Review and Diffu K Label ). Patient was hospitalized.

6697206-8 | Cough, Dyspnoea, Extravasation, Pleural Effusion
on Apr 15, 2010 Female patient from FRANCE , 72 years of age, was treated with Farmorubicine (View Usage). Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, extravasation, pleural effusion. Farmorubicine dosage: Unk. Patient was hospitalized.


6638078-7 | Congestive Cardiomyopathy
on Mar 05, 2010 Female patient from FRANCE , 55 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Farmorubicine (View Usage). Patient had the following side effects: congestive cardiomyopathy. Farmorubicine dosage: 100 Mg/m2, Unk. During the same period patient was treated with FLUOROURACIL (500 Mg/m2, Unk) (View Fluorouracil Review and Fluorouracil Label ), HERCEPTIN (6 Mg/kg, Unk) (View Herceptin Review and Herceptin Label ), ENDOXAN (500 Mg/m2, Unk) (View Endoxan Review and Endoxan Label ), TAXOTERE (100 Mg/m2, Unk) (View Taxotere Review and Taxotere Label ).

6582770-X | Angioedema, Urticaria
Patient was taking Farmorubicine (View Usage). After Farmorubicine was administered, patient had the following side effects: angioedema, urticaria on Feb 05, 2010 from FRANCE Additional patient health information: Male patient , 39 years of age, was diagnosed with gastric cancer and. Farmorubicine dosage: Unk. During the same period patient was treated with XELODA (2 Df Per Day) (View Xeloda Review and Xeloda Label ), ELOXATIN (Unk) (View Eloxatin Review and Eloxatin Label ), 5 FU (Unk) (View 5-fu Review and 5-fu Label ), 5 FU (Unk) (View 5-fu Review and 5-fu Label ), ZOPHREN (Unk) (View Zophren Review and Zophren Label ). Patient was hospitalized.

6546828-3 | Atrial Fibrillation, Eczema, Oedema, Pleural Effusion, Pruritus, Pyrexia, Skin Hyperpigmentation
Adverse event was reported on Jan 11, 2010 by a Female patient taking Farmorubicine (View Usage) (Dosage: 1 Df, Cyclic) . Location: FRANCE , 51 years of age, Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), eczema (What is eczema?), oedema, pleural effusion, pruritus, pyrexia, skin hyperpigmentation. During the same period patient was treated with FLUOROURACIL (1 Df, Cyclic) (View Fluorouracil Review and Fluorouracil Label ), ENDOXAN (1 Df, Cyclic) (View Endoxan Review and Endoxan Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), ONDANSETRON HCL (View Ondansetron Hcl Review and Ondansetron Hcl Label ). Patient was hospitalized.

6525018-4 | Acute Myeloid Leukaemia
on Dec 22, 2009 Female patient from FRANCE , 40 years of age, was treated with Farmorubicine (View Usage). Patient had the following side effects: acute myeloid leukaemia. Farmorubicine dosage: 200 Mg, Every 3 Days. During the same period patient was treated with FLUOROURACIL (1000 Mg, Every 3 Weeks) (View Fluorouracil Review and Fluorouracil Label ), ENDOXAN (1000 Mg, Every 3 Weeks) (View Endoxan Review and Endoxan Label ), TAXOTERE (200 Mg, Every 3 Weeks) (View Taxotere Review and Taxotere Label ), NOLVADEX (20 Mg, Unk) (View Nolvadex Review and Nolvadex Label ).

6464572-8 | Congestive Cardiomyopathy
on Nov 19, 2009 Female patient from FRANCE , 55 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Farmorubicine (View Usage). After Farmorubicine was administered, patient had the following side effects: congestive cardiomyopathy. Farmorubicine dosage: 100 Mg/m2, Unk. During the same period patient was treated with FLUOROURACIL (100 Mg/m2, Unk) (View Fluorouracil Review and Fluorouracil Label ), HERCEPTIN (450 Mg, Every 3 Weeks) (View Herceptin Review and Herceptin Label ), ENDOXAN (500 Mg/m2, Unk) (View Endoxan Review and Endoxan Label ), TAXOTERE (100 Mg/m2, Unk) (View Taxotere Review and Taxotere Label ).